Search Results - "CACCIAPUOTI, Anthony"
-
1
Discovery of a Novel Class of Orally Active Antifungal β-1,3-d-Glucan Synthase Inhibitors
Published in Antimicrobial Agents and Chemotherapy (01-11-2011)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
2
Pharmacodynamics of a New Triazole, Posaconazole, in a Murine Model of Disseminated Candidiasis
Published in Antimicrobial Agents and Chemotherapy (01-01-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
3
Interaction between Posaconazole and Caspofungin in Concomitant Treatment of Mice with Systemic Aspergillus Infection
Published in Antimicrobial Agents and Chemotherapy (01-07-2006)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
4
Activity of Posaconazole Combined with Amphotericin B against Aspergillus flavus Infection in Mice: Comparative Studies in Two Laboratories
Published in Antimicrobial Agents and Chemotherapy (01-03-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
Interaction between Posaconazole and Amphotericin B in Concomitant Treatment against Candida albicans In Vivo
Published in Antimicrobial Agents and Chemotherapy (01-02-2005)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
6
Cytokine Networking in Lungs of Immunocompetent Mice in Response to Inhaled Aspergillus fumigatus
Published in Infection and Immunity (01-03-2001)“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
7
Effect of Granulocyte Colony-Stimulating Factor Combination Therapy on Efficacy of Posaconazole (SCH56592) in an Inhalation Model of Murine Pulmonary Aspergillosis
Published in Antimicrobial Agents and Chemotherapy (01-08-2004)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
8
Pharmacokinetics of SCH 56592, a New Azole Broad-Spectrum Antifungal Agent, in Mice, Rats, Rabbits, Dogs, and Cynomolgus Monkeys
Published in Antimicrobial Agents and Chemotherapy (01-03-2000)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
9
Inactivation of Sterol Δ5,6-Desaturase Attenuates Virulence in Candida albicans
Published in Antimicrobial Agents and Chemotherapy (01-09-2005)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
10
Efficacy of an Evernimicin (SCH27899) In Vitro and in an Animal Model of Lyme Disease
Published in Antimicrobial Agents and Chemotherapy (01-03-2001)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
11
In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, againstAspergillus and Candida
Published in Antimicrobial Agents and Chemotherapy (01-08-2000)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
12
Nonfilamentous C. albicans Mutants Are Avirulent
Published in Cell (05-09-1997)“…Candida albicans and Saccharomyces cerevisiae switch from a yeast to a filamentous form. In Saccharomyces, this switch is controlled by two regulatory…”
Get full text
Journal Article -
13
The synthesis and structure–activity relationship of pyridazinones as glucan synthase inhibitors
Published in Bioorganic & medicinal chemistry letters (15-03-2011)“…A structure–activity relationship study of the lead 5-[4-(benzylsulfonyl)piperazin-1-yl]-4-morpholino-2-phenyl-pyridazin-3(2 H)-one 1 has resulted in the…”
Get full text
Journal Article -
14
Lead optimization of a sulfonylurea-based piperazine pyridazinone series of glucan synthase inhibitors
Published in Bioorganic & medicinal chemistry letters (15-07-2012)“…The structure–activity relationship studies of a novel sulfonylurea series of piperazine pyridazine-based small molecule glucan synthase inhibitors is…”
Get full text
Journal Article -
15
The optimization of pyridazinone series of glucan synthase inhibitors
Published in Bioorganic & medicinal chemistry letters (15-08-2012)“…A detailed structure–activity relationship study of a novel series of pyridazine-based small molecule glucan synthase inhibitors is described. The optimization…”
Get full text
Journal Article -
16
Efficacy of posaconazole and amphotericin B in experimental invasive pulmonary aspergillosis in dexamethasone immunosuppressed rats
Published in Journal of antimicrobial chemotherapy (01-11-2007)“…Objectives Invasive pulmonary aspergillosis is associated with high mortality. To assess new antifungal therapy options, animal models have to be developed to…”
Get full text
Journal Article -
17
In vitro and in vivo activities of SCH 56592 (Posaconazole), a new triazole antifungal agent, against Aspergillus and Candida
Published in Antimicrobial agents and chemotherapy (01-08-2000)“…SCH 56592 (posaconazole), a new triazole antifungal agent, was tested in vitro, and its activity was compared to that of itraconazole against 39 Aspergillus…”
Get full text
Journal Article -
18
Posaconazole (Noxafil, SCH 56592), a new azole antifungal drug, was a discovery based on the isolation and mass spectral characterization of a circulating metabolite of an earlier lead (SCH 51048)
Published in Journal of mass spectrometry. (01-04-2008)“…Posaconazole (SCH 56592) is a novel triazole antifungal drug that is marketed in Europe and the United States under the trade name 'Noxafil' for prophylaxis…”
Get full text
Journal Article -
19
Inactivation of sterol Delta5,6-desaturase attenuates virulence in Candida albicans
Published in Antimicrobial agents and chemotherapy (01-09-2005)“…Two clinical Candida albicans isolates that exhibited high-level resistance to azoles and modest decreases in susceptibility to amphotericin B were cultured…”
Get full text
Journal Article -
20
Inactivation of Sterol Δ 5,6 -Desaturase Attenuates Virulence in Candida albicans
Published in Antimicrobial agents and chemotherapy (01-09-2005)“…Two clinical Candida albicans isolates that exhibited high-level resistance to azoles and modest decreases in susceptibility to amphotericin B were cultured…”
Get full text
Journal Article